Category: Vaccine
UK.GOV: Vaccine booster doses wane after just 10 weeks
“The latest data suggests this extra protection starts to wane more rapidly, being about 15 to 25% lower from 10 weeks after the booster dose.” More...
Imperial College: Omicron is NOT milder than Delta
“We find no evidence (for both risk of hospitalisation attendance and symptom status) of Omicron having different severity from Delta, though data on hospitalisations are still very limited… Omicron was associated with a 5.41 fold higher relative risk of reinfection compared with Delta.” More...
UK GP: Omicron kills in the same way as classic covid in the elderly
“Omicron spreads like wildfire. Omicron went from one patient in a ward, to 8 patients and 4 staff infected overnight, to 5 wards full (mostly hospital acquired) 4 days later. More...
Is Delta using Omicron to evade vaccine protection?
A very disturbing development with Delta vaccine breakthrough infections has occurred in Denmark within the last day or so. More...
Plague Island: highest ever UK Covid case rate, Omicron now dominant in London
Another dismal Covid record has been broken in Britain today. More...
Sinovac vaccine not able to produce adequate antibodies to neutralise Omicron
The Covid-19 vaccine by Sinovac Biotech is not able to produce adequate antibodies to neutralise the highly mutated coronavirus strain Omicron, according to new research from the University of Hong Kong. More...
Denmark: ~90% of Omicron cases are double or triple vaccinated *17 UPDATES*
Denmark’s SSI has revealed that the vast majority of people currently infected with the Omicron variant are double or triple vaccinated. More...
UKHSA Technical Briefing 31, dated 10th December 2021
“If Omicron continues to grow at the present rate, Omicron is projected to reach parity with Delta in mid-December.” More...
UKHSA bombshell: Effectiveness of COVID-19 vaccines against the Omicron variant
“Among those who had received 2 doses of [AstraZeneca], there was NO protective effect of vaccination against symptomatic disease with Omicron from 15 weeks after the second dose.” More...
Vaccines: Pfizer CEO says fourth dose of vaccine may be needed sooner than expected
Pfizer CEO Albert Bourla said Wednesday that people might need a fourth Covid-19 shot sooner than expected after preliminary research shows the new Omicron variant can undermine protective antibodies generated by the vaccine the company developed with BioNTech. More...